HIV Study Among Top Ten Breakthroughs of 2020

Science magazine’s annual research list includes landmark study of elite controllers

• amfAR Partners with CytoDyn to Expand HIV Cure Strategy
• Prospects for an HIV/AIDS Cure: Opinions of People with HIV and Their Healthcare Providers
• What Are the COVID Risks for People Living with HIV?

PEPFAR in the Age of COVID-19: The Need for Supplemental Funding

PEPFAR faces a budget hole of $1 billion as a result of costly adaptations necessitated by COVID-19.

• Deaths Related to HIV Drop by Half in U.S.
• amfAR Study Wins Elsevier Atlas Award
• Long-Acting Injectable Prevents HIV in Women

ViiV Healthcare and TREAT Asia Partner on Important New Study of Young Adults with HIV

amfAR’s TREAT Asia program to address key questions concerning transition from pediatric to adult care

• amfAR’s Greg Millett Presents at Smithsonian World AIDS Day Event
• Global Anti-HIV Drug Supplies Running Low
• COVID-19 Pandemic Threatens HIV Drug Supplies

Connections #2 COVID & HIV – Tom Perrault & Sal Giambanco

Tom Perrault and Sal Giambanco discuss their experience of COVID-19 and the parallels between COVID and HIV. Tom also talks about his participation in an amfAR clinical trial aimed at “training” the body to control HIV without antiretroviral medication.

COVID-19 and HIV/AIDS

We are constantly gathering new information to keep you up to date on the intersection between HIV and COVID-19. The hard-won lessons of HIV research are informing the race to find effective treatments and a vaccine for COVID-19.

Natural Killer Cells: Key to a Cure?

Natural killer cells have shown promise in the treatment of cancer. amfAR grantees Dr. Timothy Schacker and Dr. Jerome Zack discuss their potential use in HIV cure strategies.